Artificial pancreas put to the test in teens over two years

NCT ID NCT04510506

Completed Disease control Sponsor: University of Virginia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well an artificial pancreas system (the Tandem t:slim pump with Control-IQ Technology) works for teenagers with Type 1 Diabetes during puberty. It followed 42 adolescents aged 11-13 for two years, comparing the device to usual care. The goal was to see if the system helps control blood sugar and how the body's insulin needs change over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tandem t:slim insulin pump with Control-IQ Technology (artificial pancreas device)
What this could lead to: If successful, this could show that the artificial pancreas system helps teenagers with Type 1 Diabetes maintain better blood sugar control during puberty.
What could go wrong: This is a small, completed study with only 42 participants, so results may not apply to all teens. The device is already FDA-approved for older teens, so the main question is about long-term effects during puberty.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

University of Virginia Center for Diabetes Technology

Charlottesville, Virginia, 22904, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.